IND.210: A randomized phase 2 trial of FOLFOX6/bevacizumab with or without reovirus (Reo) in patients (pts) with metastatic colorectal cancer (mCRC). Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Tang, Patricia A
  • Jonker, Derek J
  • Kennecke, Hagen F
  • Welch, Stephen
  • Cripps, M Christine
  • Asmis, Timothy R
  • Chalchal, Haji I
  • Tomiak, Anna T
  • Ko, Yoo-Joung
  • Chen, Eric
  • Alcindor, Thierry
  • Goffin, John
  • Theis, Ashley
  • Gill, George M
  • Tu, Dongsheng
  • Seymour, Lesley

publication date

  • May 20, 2016